InvestSMART

AFT Pharmaceuticals Limited (ASX: AFP) - Announcements

- Current share price for AFP : $3.290

ASX company news and announcements for AFT Pharmaceuticals Limited (AFP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AFT Pharmaceuticals Limited (AFP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AFT Pharmaceuticals Limited (AFP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AFT Pharmaceuticals Limited (AFP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$345 AFT reports ongoing sales growth and R&D progress 7 Jul 2026 7:30AM $3.040 $3.290 risen by 8.22%
$345 Notice of Annual Meeting of Shareholders 2026 2 Jul 2026 3:17PM $3.010 $3.290 risen by 9.30%
$345 Update - Dividend/Distribution - AFP 24 Jun 2026 1:54PM $3.040 $3.290 risen by 8.22%
$345 FDA allows AFT injectable iron project clinical study 24 Jun 2026 7:31AM $3.010 $3.290 risen by 9.30%
$345 FDA allows AFT injectable iron project clinical study 24 Jun 2026 7:31AM $3.010 $3.290 risen by 9.30%
$345 Application for quotation of securities - AFP 22 Jun 2026 8:13AM $3.010 $3.290 risen by 9.30%
$345 Capital Change Notice 22 Jun 2026 7:57AM $3.010 $3.290 risen by 9.30%
$345 Update - Dividend/Distribution - AFP 26 May 2026 7:33AM $3.030 $3.290 risen by 8.58%
$345 Annual Meeting and Closing Date for Director Nominations 25 May 2026 7:32AM $3.050 $3.290 risen by 7.87%
$345 Dividend/Distribution - AFP 22 May 2026 1:16PM $3.050 $3.290 risen by 7.87%
$345 Issue of unlisted options 22 May 2026 8:30AM $3.050 $3.290 risen by 7.87%
$345 Dividend distribution update 21 May 2026 10:07AM $2.930 $3.290 risen by 12.29%
$345 FY26 NZX App2 21 May 2026 7:31AM $2.860 $3.290 risen by 15.03%
$345 FY26 Annual Report 21 May 2026 7:30AM $2.860 $3.290 risen by 15.03%
$345 FY26 results presentation 21 May 2026 7:30AM $2.860 $3.290 risen by 15.03%
$345 FY26 results 21 May 2026 7:30AM $2.860 $3.290 risen by 15.03%
$345 AFT Pharmaceuticals names Stuart Houliston CFO 18 May 2026 7:30AM $2.730 $3.290 risen by 20.51%
$345 AFT to release FY26 results 12 May 2026 7:30AM $3.190 $3.290 risen by 3.13%
$345 March Quarter FY 2026 Investor Update 7 Apr 2026 7:30AM $2.730 $3.290 risen by 20.51%
$345 Chief Financial Officer update 24 Mar 2026 10:47AM $2.730 $3.290 risen by 20.51%
$345 Court of Appeal dismisses PBL Port Wine Stain profit claim 9 Mar 2026 7:40AM $3.100 $3.290 risen by 6.13%
$345 December Quarter FY 2026 Investor Update 15 Jan 2026 7:30AM $2.970 $3.290 risen by 10.77%
$345 FY26 Interim presentation 20 Nov 2025 7:31AM $2.710 $3.290 risen by 21.40%
$345 FY26 Interim Report 20 Nov 2025 7:31AM $2.710 $3.290 risen by 21.40%
$345 FY26 Interim release 20 Nov 2025 7:31AM $2.710 $3.290 risen by 21.40%

1 - 25 of 538 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.